These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

571 related items for PubMed ID: 18230658

  • 1. A functional anti-mullerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients.
    Kevenaar ME, Laven JS, Fong SL, Uitterlinden AG, de Jong FH, Themmen AP, Visser JA.
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1310-6. PubMed ID: 18230658
    [Abstract] [Full Text] [Related]

  • 2. Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance.
    Zheng MX, Li Y, Hu R, Wang FM, Zhang XM, Guan B.
    J Assist Reprod Genet; 2016 Feb; 33(2):199-205. PubMed ID: 26732661
    [Abstract] [Full Text] [Related]

  • 3. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.
    Akush Ginekol (Sofiia); 2013 Feb; 52 Suppl 1():16-23. PubMed ID: 24294740
    [Abstract] [Full Text] [Related]

  • 4. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS.
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [Abstract] [Full Text] [Related]

  • 5. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
    Pierre A, Peigné M, Grynberg M, Arouche N, Taieb J, Hesters L, Gonzalès J, Picard JY, Dewailly D, Fanchin R, Catteau-Jonard S, di Clemente N.
    Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213
    [Abstract] [Full Text] [Related]

  • 6. Variants in the ACVR1 gene are associated with AMH levels in women with polycystic ovary syndrome.
    Kevenaar ME, Themmen AP, van Kerkwijk AJ, Valkenburg O, Uitterlinden AG, de Jong FH, Laven JS, Visser JA.
    Hum Reprod; 2009 Jan; 24(1):241-9. PubMed ID: 18854405
    [Abstract] [Full Text] [Related]

  • 7. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
    Alebić MŠ, Stojanović N, Duhamel A, Dewailly D.
    Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
    [Abstract] [Full Text] [Related]

  • 8. Anti-Müllerian hormone level is associated with vitamin D receptor polymorphisms in women with polycystic ovary syndrome.
    Szafarowska M, Dziech E, Kaleta B, Kniotek M, Rogowski A, Segiet-Święcicka A, Jerzak M.
    J Assist Reprod Genet; 2019 Jun; 36(6):1281-1289. PubMed ID: 31089932
    [Abstract] [Full Text] [Related]

  • 9. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.
    Dewailly D, Pigny P, Soudan B, Catteau-Jonard S, Decanter C, Poncelet E, Duhamel A.
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4399-405. PubMed ID: 20610596
    [Abstract] [Full Text] [Related]

  • 10. Increased frequency of the anti-mullerian-inhibiting hormone receptor 2 (AMHR2) 482 A>G polymorphism in women with polycystic ovary syndrome: relationship to luteinizing hormone levels.
    Georgopoulos NA, Karagiannidou E, Koika V, Roupas ND, Armeni A, Marioli D, Papadakis E, Welt CK, Panidis D.
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1866-70. PubMed ID: 23969185
    [Abstract] [Full Text] [Related]

  • 11. Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary.
    Dewailly D, Robin G, Peigne M, Decanter C, Pigny P, Catteau-Jonard S.
    Hum Reprod Update; 2016 Nov; 22(6):709-724. PubMed ID: 27566840
    [Abstract] [Full Text] [Related]

  • 12. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N, Pehlivanov B, Orbecova M, Uchikova E, Ivancheva H.
    Akush Ginekol (Sofiia); 2014 Nov; 53(5):22-7. PubMed ID: 25558667
    [Abstract] [Full Text] [Related]

  • 13. The role of anti-Müllerian hormone in the pathogenesis and pathophysiological characteristics of polycystic ovary syndrome.
    Qi X, Pang Y, Qiao J.
    Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():82-7. PubMed ID: 26914398
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome.
    Pigny P, Jonard S, Robert Y, Dewailly D.
    J Clin Endocrinol Metab; 2006 Mar; 91(3):941-5. PubMed ID: 16368745
    [Abstract] [Full Text] [Related]

  • 19. Anti-müllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries.
    Stubbs SA, Hardy K, Da Silva-Buttkus P, Stark J, Webber LJ, Flanagan AM, Themmen AP, Visser JA, Groome NP, Franks S.
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5536-43. PubMed ID: 16030171
    [Abstract] [Full Text] [Related]

  • 20. Anti-Müllerian hormone and anti-Müllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women.
    Kevenaar ME, Themmen AP, Laven JS, Sonntag B, Fong SL, Uitterlinden AG, de Jong FH, Pols HA, Simoni M, Visser JA.
    Hum Reprod; 2007 Jun; 22(6):1547-54. PubMed ID: 17337470
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.